Katarina Sjögreen Gleisner
31 – 40 of 85
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
(
- Contribution to journal › Article
- 2018
-
Mark
From fixed activities to personalized treatments in radionuclide therapy : lost in translation?
(
- Contribution to journal › Article
-
Mark
Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals
(
- Contribution to journal › Article
-
Mark
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
(
- Contribution to journal › Article
-
Mark
A method for tumor dosimetry based on hybrid planar-SPECT/CT images and semiautomatic segmentation
(
- Contribution to journal › Article
-
Mark
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
(
- Contribution to journal › Article
-
Mark
3-D Image-Based Dosimetry in Radionuclide Therapy
(
- Contribution to journal › Scientific review
- 2017
-
Mark
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
(
- Contribution to journal › Article
-
Mark
Dosimetry-based treatment planning for molecular radiotherapy : A summary of the 2017 report from the Internal Dosimetry Task Force
(
- Contribution to journal › Scientific review
-
Mark
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
(
- Contribution to journal › Article